Delivery Order SPE2DB20D2104-SPE2DB23FV44Q
- Not listed
- This federal contract award, with ID SPE2DB20D3101|SPE2DB24FRAJ2, was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is for the delivery of Pantoprazole Sodium Delayed-Release 40 mg Tablets in 1,000-count quantities, with a ceiling value of $1,422.08. The contract is a Delivery Order under an Indefinite Delivery Contract (IDC) held by Cencora, Inc. with the DLA Troop Support Medical. This IDC, valued at up to $999,999,999.00,...
- This federal contract award, valued at $3,891.46, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is for the delivery of Pantoprazole Sodium Delayed-Release 40 mg Tablets in 1,000-count bottles. The contract is a delivery order under a larger Indefinite Delivery Contract (IDC) held by Cencora, Inc. with the DLA Troop Support Medical, valued at up to $999,999,999.00 and running through December 2025. This IDC serves as...
- This federal contract award, with a ceiling value of $5,396.04, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is for the delivery of 4,555,550,336 units of Pantoprazole Sodium Delayed-Release 40 mg Tablets. The contract is a Delivery Order under an Indefinite Delivery Contract (IDC) that Cencora, Inc. holds with the DLA Troop Support Medical, valued at up to $999,999,999.00 and running through December 2025. This IDC...
- This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The award, valued at $1,141.71, is for the delivery of 4,563,619,057 units of the prescription drug Pantoprazole Sodium Delayed Release 40 mg Tablets in quantities of 1,000. The contract has a firm fixed price and an ultimate completion date of February 12, 2024. No set-aside designation was used for this award. Amerisourcebergen Drug Corp...
- This contract award for $3,710.28 was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is for the delivery of 4,555,960,079 units of Pantoprazole Sodium Delayed-Release 40 mg Tablets. The contract is a Firm Fixed Price Delivery Order with a completion date of January 19, 2022. The award was made without any set-aside designation, indicating open competition. Amerisourcebergen Drug Corp holds a significant $999,999,999...
- This federal contract award, with the ID SPE2DB22D3010|SPE2DB24FP1NR, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The contract is for the delivery of 4,563,501,970 units of Pantoprazole Sodium Delayed-Release 40 mg Tablets in quantities of 1,000 per bottle, with a completion date of February 1, 2024 and a ceiling value of $1,265.73. The contract is a Delivery Order, with a Firm Fixed Price pricing type, and was...
- This federal contract award, with ID SPE2DB22D3004|SPE2DB24FQE54, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award, valued at $1,132.94, is for the delivery of 4,564,451,658 units of Pantoprazole Sodium Delayed-Release 40 mg Tablets 1000s. This is a Firm Fixed Price delivery order contract with a completion date of May 1, 2024. The contract does not have a set-aside designation,...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $8,169.21, is for the delivery of Pantoprazole Sodium Delayed-Release Tablets, 40 mg, in 1,000-count quantities. This is a delivery order awarded under an Indefinite Delivery Contract (IDC) held by Amerisourcebergen's parent company, Cencora, Inc., with the DLA Troop Support Medical, valued at up...
- This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $1,439.74 firm fixed-price delivery order is for the supply of 1,000 units of Pantoprazole Sodium Delayed-Release 40 mg tablets. The contract has an ultimate completion date of February 5, 2024 and was awarded on February 2, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at up to...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division, a major pharmaceutical distributor, for the supply of Pantoprazole Sodium Delayed-Release (DR) 40 mg tablets. The contract has a ceiling value of $1,680.79 and is a Firm Fixed Price Delivery Order, with a period of performance through June 3, 2024. This contract award is associated with a larger Indefinite Delivery Contract (IDC) valued up to $999,999,999.00...
- SPE2DB20D2104Indefinite Delivery Contract
- SPE2DB20D2104-SPE2DB23FV44QDelivery Order
This federal contract award, with an ID of SPE2DB20D2104|SPE2DB23FV44Q, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The award is for the delivery of 4,562,252 units of Pantoprazole Sodium Delayed-Release 40 mg tablets. The contract has a ceiling value of $1,325.52 and a completion date of September 21, 2023. The contract type is Delivery Order with a Firm Fixed Price pricing structure. This award is not designated as a set-aside contract. The parent company, Cencora, Inc., maintains a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00 through December 2025, which serves as the primary vehicle for the company to provide a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.3k | 9/20/23 |